{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T16:00:02Z","timestamp":1771603202730,"version":"3.50.1"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:p>\n                    Sustained ventricular tachycardia (VT) and fibrillation-related sudden cardiac death account for nearly 450,000 deaths annually in the United States. Catheter ablation (CA) and antiarrhythmic drugs (AADs) are commonly used to manage VT recurrence; however, their comparative efficacy and safety remain uncertain. We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) comparing CA and AADs in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillators (ICDs). PubMed, Embase, and Cochrane Cochrane Central Register of Controlled Trials (CENTRAL) Library were searched up to February 15, 2025. Primary outcomes included all-cause mortality, cardiovascular mortality, VT storm, and appropriate ICD shock. Secondary outcomes included inappropriate ICD shock, appropriate antitachycardia pacing, heart failure hospitalization, stroke\/transient ischemic attack, and myocardial infarction. Risk ratios (RRs) with 95% confidence intervals (CIs) were pooled using a random-effects model. Three RCTs encompassing 587 patients (287 CA, 300 AADs) were included. No significant differences were found between CA and AADs in all-cause mortality (RR, 0.88; 95% CI, 0.63\u20131.22;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.43), cardiovascular mortality (RR, 1.23; 95% CI, 0.77\u20131.98;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.39), VT storm (RR, 0.76; 95% CI, 0.39\u20131.46;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.41), or appropriate ICD shock (RR, 0.87; 95% CI, 0.69\u20131.10;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.24). Secondary outcomes, including inappropriate ICD shock, antitachycardia pacing, heart failure hospitalization, stroke\/transient ischemic attack, and myocardial infarction, were also comparable between the 2 groups. In this meta-analysis of RCTs, CA and AADs demonstrated comparable efficacy and safety in patients with VT. Larger high-quality trials are warranted to confirm these findings and further define the role of CA as a potential first-line therapy.\n                  <\/jats:p>","DOI":"10.1097\/hpc.0000000000000407","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T18:00:27Z","timestamp":1762279227000},"page":"e0407","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Catheter Ablation Versus Antiarrhythmic Drugs for Ventricular Tachycardia: A Systematic Review and Meta-Analysis"],"prefix":"10.1097","volume":"25","author":[{"given":"Sufyan","family":"Shahid","sequence":"first","affiliation":[{"name":"Khawaja Muhammad Safdar Medical College, Sialkot, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shehroze","family":"Tabassum","sequence":"additional","affiliation":[{"name":"King Edward Medical University, Lahore, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Abdullah","family":"Ali","sequence":"additional","affiliation":[{"name":"Khyber Medical College, Peshawar, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umama","family":"Alam","sequence":"additional","affiliation":[{"name":"Khyber Medical College, Peshawar, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoya","family":"Ejaz","sequence":"additional","affiliation":[{"name":"Allama Iqbal Medical College, Lahore, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaryab","family":"Bacha","sequence":"additional","affiliation":[{"name":"Khyber Medical College, Peshawar, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subtain Haider","family":"Solahri","sequence":"additional","affiliation":[{"name":"Khawaja Muhammad Safdar Medical College, Sialkot, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hritvik","family":"Jain","sequence":"additional","affiliation":[{"name":"All India Institute of Medical Sciences, Jodhpur, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salman","family":"Khalid","sequence":"additional","affiliation":[{"name":"Oklahoma Heart Hospital, Oklahoma City, Oklahoma, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raheel","family":"Ahmed","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London, London, UK."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"R1-20260220","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1161\/CIRCULATIONAHA.109.192666","article-title":"Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association.","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"key":"R2-20260220","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJM199711273372202","article-title":"A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.","volume":"337","year":"1997","journal-title":"N Engl J Med"},{"key":"R3-20260220","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.jacc.2013.04.083","article-title":"Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.","volume":"62","author":"Powell","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R4-20260220","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10840-022-01287-w","article-title":"A systematic review and meta-analysis comparing radiofrequency catheter ablation with medical therapy for ventricular tachycardia in patients with ischemic and non-ischemic cardiomyopathies.","volume":"66","author":"Ravi","year":"2023","journal-title":"J Interv Card Electrophysiol"},{"key":"R5-20260220","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10840-019-00663-3","article-title":"2019 HRS\/EHRA\/APHRS\/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.","volume":"59","author":"Cronin","year":"2020","journal-title":"J Interv Card Electrophysiol"},{"key":"R6-20260220","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.jacc.2022.01.050","article-title":"Substrate ablation vs antiarrhythmic drug therapy for symptomatic ventricular tachycardia.","volume":"79","author":"Arenal","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R7-20260220","first-page":"e210","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary.","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"key":"R8-20260220","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1056\/NEJMoa2409501","article-title":"Catheter ablation or antiarrhythmic drugs for ventricular tachycardia.","volume":"392","author":"Sapp","year":"2024","journal-title":"N Engl J Med"},{"key":"R9-20260220","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s10840-023-01471-6","article-title":"Treatment of ventricular tachycardia with catheter ablation versus anti-arrhythmic drug titration: a systematic review and meta-analysis of randomized controlled trials.","volume":"66","author":"Ahmed","year":"2023","journal-title":"J Interv Card Electrophysiol"},{"key":"R10-20260220","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.hrthm.2016.03.004","article-title":"Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: a systematic review and meta-analysis of randomized controlled trials.","volume":"13","author":"Santangeli","year":"2016","journal-title":"Heart Rhythm"},{"key":"R11-20260220","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0735-1097(98)81159-5","article-title":"Randomized controlled trial of ventricular tachycardia treatment by cooled tip catheter ablation vs drug therapy.","volume":"31","author":"Epstein","year":"1998","journal-title":"JACC"}],"container-title":["Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HPC.0000000000000407","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T15:00:39Z","timestamp":1771599639000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/HPC.0000000000000407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/hpc.0000000000000407","relation":{},"ISSN":["1535-2811"],"issn-type":[{"value":"1535-2811","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]}}}